Xcout IntelGemphire competitors & alternatives
Gemphire Therapeutics was a U.S. clinical-stage biopharmaceutical company developing gemcabene, an investigational lipid-modulating drug intended to treat dyslipidemia and…
See who competes with Gemphire
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Gemphire →Already a subscriber? Sign in
Xcout Intel tracks Gemphire continuously — this profile deepens as new filings, funding, people and hiring data arrive.